Cargando…

Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial

BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Appleton, Jason P., Woodhouse, Lisa J., Bereczki, Daniel, Berge, Eivind, Christensen, Hanne K., Collins, Rónán, Gommans, John, Ntaios, George, Ozturk, Serefnur, Szatmari, Szabolcs, Wardlaw, Joanna M., Sprigg, Nikola, Rothwell, Peter M., Bath, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358219/
https://www.ncbi.nlm.nih.gov/pubmed/30626285
http://dx.doi.org/10.1161/STROKEAHA.118.023190
_version_ 1783391971058909184
author Appleton, Jason P.
Woodhouse, Lisa J.
Bereczki, Daniel
Berge, Eivind
Christensen, Hanne K.
Collins, Rónán
Gommans, John
Ntaios, George
Ozturk, Serefnur
Szatmari, Szabolcs
Wardlaw, Joanna M.
Sprigg, Nikola
Rothwell, Peter M.
Bath, Philip M.
author_facet Appleton, Jason P.
Woodhouse, Lisa J.
Bereczki, Daniel
Berge, Eivind
Christensen, Hanne K.
Collins, Rónán
Gommans, John
Ntaios, George
Ozturk, Serefnur
Szatmari, Szabolcs
Wardlaw, Joanna M.
Sprigg, Nikola
Rothwell, Peter M.
Bath, Philip M.
author_sort Appleton, Jason P.
collection PubMed
description BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). METHODS—: Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. RESULTS—: Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37–1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, −2.03; 95% CI, −2.84 to −1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12–2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. CONCLUSIONS—: Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study.
format Online
Article
Text
id pubmed-6358219
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-63582192019-02-20 Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial Appleton, Jason P. Woodhouse, Lisa J. Bereczki, Daniel Berge, Eivind Christensen, Hanne K. Collins, Rónán Gommans, John Ntaios, George Ozturk, Serefnur Szatmari, Szabolcs Wardlaw, Joanna M. Sprigg, Nikola Rothwell, Peter M. Bath, Philip M. Stroke Original Contributions BACKGROUND AND PURPOSE—: Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). METHODS—: Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. RESULTS—: Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37–1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, −2.03; 95% CI, −2.84 to −1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12–2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. CONCLUSIONS—: Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study. Lippincott Williams & Wilkins 2019-02 2019-01-10 /pmc/articles/PMC6358219/ /pubmed/30626285 http://dx.doi.org/10.1161/STROKEAHA.118.023190 Text en © 2019 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Contributions
Appleton, Jason P.
Woodhouse, Lisa J.
Bereczki, Daniel
Berge, Eivind
Christensen, Hanne K.
Collins, Rónán
Gommans, John
Ntaios, George
Ozturk, Serefnur
Szatmari, Szabolcs
Wardlaw, Joanna M.
Sprigg, Nikola
Rothwell, Peter M.
Bath, Philip M.
Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title_full Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title_fullStr Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title_full_unstemmed Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title_short Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke: Data From the ENOS Trial
title_sort effect of glyceryl trinitrate on hemodynamics in acute stroke: data from the enos trial
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358219/
https://www.ncbi.nlm.nih.gov/pubmed/30626285
http://dx.doi.org/10.1161/STROKEAHA.118.023190
work_keys_str_mv AT appletonjasonp effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT woodhouselisaj effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT bereczkidaniel effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT bergeeivind effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT christensenhannek effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT collinsronan effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT gommansjohn effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT ntaiosgeorge effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT ozturkserefnur effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT szatmariszabolcs effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT wardlawjoannam effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT spriggnikola effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT rothwellpeterm effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial
AT bathphilipm effectofglyceryltrinitrateonhemodynamicsinacutestrokedatafromtheenostrial